{"result": {"id": "chatcmpl-674", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **Aflibercept** is an anti-angiogenic drug that inhibits the formation of new blood vessels by targeting vascular endothelial growth factor (VEGF). It is administered as an injection to mice and has been studied for its efficacy in treating various conditions, including eye diseases.  Specifically, it targets neovascularization and acts as an anti-VEGF antibody, helping to manage retinal fluid buildup. **Aflibercept** is categorized as a drug used for treatment purposes and is effective in managing inflammatory central nervous system (CNV) conditions, such as age-related macular degeneration (AMD). It's also used in research settings. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743240705, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 129, "prompt_tokens": 338, "total_tokens": 467, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"AFLIBERCEPT\"\nDescription List: [\"The **AFLIBERCEPT** is an anti-angiogenic drug, meaning it inhibits the formation of new blood vessels. It is also an anti-vascular endothelial growth factor agent, specifically targeting vascular endothelial growth factor (VEGF). In a study involving mice, AFLIBERCEPT was administered as an injection to these animals. \\n\", \"The **Aflibercept** is a drug used to treat various conditions, including those related to eye diseases. It specifically targets neovascularization and acts as an anti-VEGF antibody, helping to manage retinal fluid buildup.  It's also categorized as a drug used for treatment purposes. In the context of anti-angiogenesis therapy for myopic central nervous system (CNV), **Aflibercept** is an anti-VEGF agent known by its drug name. It is particularly effective in treating inflammatory CNV and other eye conditions, including age-related macular degeneration (AMD).  It's also used in research settings. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_74af54db767f762ccd55c1e9cf22dbf8fe62352bedf2468a4289dcd5ff555d4b_v2"}